- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Quantifying beta cell function in the preclinical stages of type 1 diabetes ; volume:66 ; number:12 ; day:15 ; month:9 ; year:2023 ; pages:2189-2199 ; date:12.2023
Diabetologia ; 66, Heft 12 (15.9.2023), 2189-2199, 12.2023
- Urheber
-
Galderisi, Alfonso
Carr, Alice L. J.
Martino, Mariangela
Taylor, Peter
Senior, Peter
Dayan, Colin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-023-06011-5
- URN
-
urn:nbn:de:101:1-2024012309055220749959
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Galderisi, Alfonso
- Carr, Alice L. J.
- Martino, Mariangela
- Taylor, Peter
- Senior, Peter
- Dayan, Colin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Latter-stage preclinical developmental work on PL69/DM1157
L-Arginine in diabetes: clinical and preclinical evidence
P2.51 Preclinical Atherosclerotic Disease and Metabolic Syndrome: A Prediabetes Stage?
Correction: L-Arginine in diabetes: clinical and preclinical evidence
Quantifying the Life Stages of a Biomolecule: Implications for the Circadian Transcriptome
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2
Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
Preclinical hyperthermia
Die Serum-Beta-Glukuronidase-Aktivität bei Diabetes mellitus
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
Latter-stage preclinical developmental work on PL69/DM1157
L-Arginine in diabetes: clinical and preclinical evidence
P2.51 Preclinical Atherosclerotic Disease and Metabolic Syndrome: A Prediabetes Stage?
Correction: L-Arginine in diabetes: clinical and preclinical evidence
Quantifying the Life Stages of a Biomolecule: Implications for the Circadian Transcriptome
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2
Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
Preclinical hyperthermia
Die Serum-Beta-Glukuronidase-Aktivität bei Diabetes mellitus
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
Latter-stage preclinical developmental work on PL69/DM1157
L-Arginine in diabetes: clinical and preclinical evidence
P2.51 Preclinical Atherosclerotic Disease and Metabolic Syndrome: A Prediabetes Stage?
Correction: L-Arginine in diabetes: clinical and preclinical evidence
Quantifying the Life Stages of a Biomolecule: Implications for the Circadian Transcriptome
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2
Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
Preclinical hyperthermia
Die Serum-Beta-Glukuronidase-Aktivität bei Diabetes mellitus
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab